Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CACYBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMCX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC23IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHSC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01091 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NCAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APTX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PPP2R5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA0 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on